Hypnotic Cognitive Therapy for Chronic Pain in Spinal Cord Injury: A Randomized Controlled Trial
Clinical Snapshot
PICO Framework
| P — Population | Community-residing adults with spinal cord injury experiencing moderate-to-severe chronic pain (n=127, mean age 51.3 years, 42% female, 15.4 years post-SCI) |
| I — Intervention | Hypnotic cognitive therapy (HYP-CT): 6 weekly 60-minute sessions delivered by psychologist via telephone or Zoom, plus daily self-hypnosis practice using session recordings |
| C — Comparator | Usual care (UC): participants encouraged to continue current treatments or seek additional pain treatments |
| O — Outcomes | Primary: average pain intensity (0-10 numerical rating scale) at 6 weeks. Secondary: pain intensity at 12 weeks, depression scores |
Bottom Line
This single-blind RCT demonstrates that hypnotic cognitive therapy delivered via telehealth produces statistically significant but modest reductions in chronic pain intensity among adults with spinal cord injury. The intervention reduced average pain by 0.55 points at 6 weeks and 0.79 points at 12 weeks on a 0-10 scale, with concurrent improvements in depression. While the effect size may not reach conventional thresholds for clinical significance, the intervention appears safe and accessible via telehealth. The study provides Class III evidence supporting HYP-CT as an adjunctive treatment option for SCI-related chronic pain. However, clinicians should consider the modest effect size, lack of functional outcome data, and need for replication studies. The intervention may be most valuable for patients with limited access to face-to-face pain psychology services or as part of a comprehensive pain management approach.
Key Findings
P Value: Statistically significant at both time points (p<0.05)
Effect Size: Small to moderate effect size, sustained at 12 weeks with -0.79 points reduction
Primary Outcome: Average pain intensity reduction at 6 weeks: -0.55 points (95% CI -1.04 to -0.06, p<0.05)
Nnt Or Sensitivity: NNT not calculable from available data; effect size suggests approximately 10-15% relative improvement
Confidence Interval: 6 weeks: -1.04 to -0.06; 12 weeks: -1.28 to -0.29
Clinical Application
High feasibility with telehealth delivery model, requiring trained psychologists and patient commitment to daily practice Relevant for Australian SCI population given limited specialist pain psychology services. Could complement existing multidisciplinary pain programs. Not PBS-subsidized but potentially cost-effective given telehealth delivery Adults with chronic SCI-related pain, particularly those with neuropathic pain components and limited access to specialist pain services
Abstract
BACKGROUND AND OBJECTIVES: Chronic pain is highly prevalent, disabling, and difficult to treat in people with spinal cord injury (SCI). Our objective was to determine whether hypnotic cognitive therapy (HYP-CT) significantly reduces average pain intensity. METHODS: This single-blind, randomized, parallel-group trial investigated the efficacy of HYP-CT in treating moderate-to-severe chronic pain in community-residing adults with SCI. Participants were recruited nationwide through SCI organizations and randomized 1:1 to HYP-CT vs usual care (UC). We used computerized permuted block randomization with variable block sizes and stratified by sex and worst pain type. HYP-CT was delivered by a psychologist over the telephone or through Zoom and consisted of 6 weekly 60-minute sessions plus instructions to practice self-hypnosis daily independently by listening to session recordings. Controls were encouraged to continue current treatments or seek additional pain treatments. The primary outcome was average pain intensity assessed 4 times per week on a 0-10 numerical rating scale and averaged. The primary end point was at 6 weeks after randomization, with a follow-up assessment at 12 weeks. All outcomes were assessed through structured telephone interviews performed by blinded assessors. RESULTS: A total of 127 participants were randomized to HYP-CT (n = 64) vs UC (n = 63). Forty-eight percent were treated over the telephone and 52% through Zoom. The group was 42% female, had a mean age of 51.3 years (15.4 years after SCI), and had a mean baseline pain intensity of 5.93. The worst pain was neuropathic in 57% of cases. The primary outcome, average pain intensity, decreased more in the HYP-CT group compared with UC controls at 6 (-0.55, 95% CI -1.04 to -0.06) and 12 (-0.79, 95% CI -1.28 to -0.29) weeks. Depression declined significantly more in the HYP-CT vs UC groups at 6 and 12 weeks. Planned exploratory analyses suggested that the effect of HYP-CT on pain intensity was similar when delivered over the telephone vs through Zoom, and that pain intensity decreased more in those with all neuropathic pain vs those with mixed pain at 12 weeks. DISCUSSION: The study suggests that HYP-CT is an effective adjunctive treatment for SCI-related pain. Replication studies are needed. TRIAL REGISTRATION INFORMATION: The study was registered on ClinicalTrials.gov (NCT03857672) on February 28, 2019 and study enrollment commenced on April 24, 2019. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that, in patients with SCI, HYP-CT improves average pain intensity at 6 weeks compared with UC.
References
- 1.Bombardier, C. H., Mendoza, M. E., Thomas, P. A., Barber, J. K., & Jensen, M. P. (2026). Hypnotic cognitive therapy for chronic pain in spinal cord injury: A randomized controlled trial. Neurology. https://doi.org/10.1212/WNL.0000000000214836
Related Research
IEEE transactions on cybernetics
Knowledge Distillation and Reinforcement Learning in a Human–Machine Collaboration Delivery System With a Robotic Arm
3 Aug 2026
The Journal of rheumatology
Examining the Role of Wearables in Inflammatory Arthritis Care: A Narrative Literature Review
3 Aug 2026
Science advances
Human-inspired time-series health evaluation with an adaptive multimodal electronic skin
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service